Delivery Order HT942523D0011-HT942526FE010
Award Date 2/1/26
Potential Completion Date 12/31/27
Potential Value $927K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.86M firm-fixed-price delivery order to Eitr Biologics, Inc. on September 20, 2024, for novel nanotherapeutics development. The San Diego-based biotechnology company will perform work through December 31, 2025. This delivery order is issued under Eitr Biologics' existing Indefinite Delivery Vehicle (IDV) contract with the Defense Health Agency, valued at $4.39M through August 2028, which focuses specifically on developing novel nanotherapeutics to combat...
- This is a $299,999.66 firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc., a for-profit biotechnology company. The contract is for the development of novel nanotherapeutics to combat viral infections and other biological threats, with a performance period through June 2026. Eitr Biologics has previously received multiple federal contract awards and grants from agencies like the Centers for Disease Control and Prevention (CDC) and the...
- The Defense Health Agency awarded a $110.5 million firm fixed-price delivery order to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company specializing in antibody-based therapeutics and medical countermeasures. The delivery order, awarded on June 6, 2025, with completion scheduled for December 4, 2025, calls for the supply of monoclonal antibodies and viral recombinant antigens. No set-aside designation was used in this award. This delivery order is issued under Mapp's...
- This federal contract award was made by the Defense Health Agency (DHA) to Erivan Bio, LLC, a for-profit limited liability company, for a Small Business Technology Transfer (STTR) Phase I research project titled "Novel Scalable Loading of Antibiotics in Exosomes for Bacterial Wound Infection Prevention". The contract has a firm fixed price of $249,981.86 and a completion date of September 22, 2024. This STTR Phase I award supports research and development to develop a novel approach...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded AN2 Therapeutics, Inc. a definitive contract valued at $18.3 million on September 20, 2022, to develop epetraborole as a novel therapeutic for melioidosis and additional antimicrobial resistant bacterial biothreat pathogens. The contract, which runs through September 30, 2026, was awarded under a Broad Agency Announcement posted in February 2021 that solicited proposals for medical countermeasures against biothreat...
- The Defense Health Agency (DHA) awarded a $1.3 million firm fixed-price contract to Advanced Cooling Technologies Inc. (ACT), a small business based in Lancaster, Pennsylvania, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, designated as a Total Small Business set-aside, supports the development of a psoralen-UV-A irradiation-based high-throughput pathogen inactivation device. The award was issued on July 2, 2025, with an ultimate completion date of...
- The Defense Health Agency awarded a $1.3M firm fixed price definitive contract to Tao Treasures, LLC (operating as Nanobiofab) on September 5, 2025, for development of a next-generation rapid infection detection platform leveraging volatile organic compound sensing and artificial intelligence. The contract, designated as a total small business set-aside, supports the creation of an advanced diagnostic system designed to enable precision infection management through non-invasive, real-time...
- Biofire Defense LLC received a delivery order valued at $74,677.60 from the Joint Program Executive Office (PEO) for Chemical and Biological Defense, a Defense Department agency, on January 14, 2026. The delivery order authorizes the purchase of multiple assays and a Spotfire system from the Salt Lake City-based diagnostic manufacturer, with completion targeted for February 27, 2026. The contract carries a firm fixed-price structure and includes no set-aside designation, reflecting Biofire...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...